B3 · BRL
AALR3
Allianca Saude e Participacoes SA - ALLIAR
- Day's range
- R$3.17 – R$3.29
- Day's volume
- R$187.7k
- 52-week range
- R$2.36 – R$6.66
Follow AALR3 on Fuolio
See how AALR3 weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountAALR3 in numbers
- Market cap
- R$501.3m
- P/E
- -0.38
- P/B
- -1.87
- Dividend yield (12m)
- 0.00%
AALR3 price history
AALR3 risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | -47.01% | -66.36% | -77.84% |
| Volatility (annualised) | 52.59% | 61.77% | 59.90% |
| Largest drawdown | -52.18% | -81.50% | -87.74% |
| Positive months | 5/12 | 16/36 | 32/60 |
How much did investing in AALR3 return?
R$1,000.00 invested on 01/11/2021 would be worth R$183.78 today.
- Value today in AALR3
- R$183.78
- Return over the period
- -81.62%
- Return per year
- -29.14%
- In the Ibovespa
- R$1,885.05
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
AALR3 fundamentals
Valuation
- P/E-0.38
- P/B-1.87
- EV/EBITDA-0.92
- EV/EBIT-0.82
- EV/Revenue0.74
- P/EBIT-0.48
- P/S0.43
- P/OCF2.50
- P/FCF1.19
- Earnings yield-122.18%
- PEG ratio—
- Earnings per share-R$9.01
- Book value per share-R$1.82
Debt
- Net debtR$351.9m
- Net debt/EBITDA—
- Net debt/Equity-1.40
- Debt/Equity-1.86
- Current ratio0.28
- Quick ratio0.28
- Cash ratio0.07
Efficiency
- Gross margin20.76%
- EBITDA margin-80.58%
- Operating margin-90.34%
- Net margin-118.89%
- Asset turnover0.65
Profitability
- ROE494.46%
- ROA-77.18%
- ROIC-1,045.42%
- Payout—
Growth
- Revenue CAGR (5 years)4.43%
- Earnings CAGR (5 years)—
- Revenue growth (year)-5.19%
- Earnings growth (year)-1,014.96%
- Revenue growth (quarter)-5.19%
- Earnings growth (quarter)-1,014.96%
AALR3 indicators by year
Multiples at each year's closing price; margins and returns from that year's accounts.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | -0.56 | -10.58 | -5.40 | -10.89 | -301.90 | -13.09 | 50.52 | 38.15 |
| P/B | -3.05 | 1.15 | 1.30 | 2.53 | 1.40 | 1.04 | 1.58 | 1.18 |
| EV/EBITDA | — | 8.65 | 13.51 | 43.30 | 12.70 | 19.23 | 11.42 | 10.63 |
| Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.57% | 0.47% | — |
| Earnings per share | -R$9.01 | -R$0.81 | -R$1.93 | -R$1.98 | -R$0.05 | -R$0.85 | R$0.36 | R$0.35 |
| Book value per share | -R$1.66 | R$7.46 | R$7.98 | R$8.55 | R$10.53 | R$10.65 | R$11.49 | R$11.31 |
| ROE | 544.08% | -10.83% | -24.14% | -23.20% | -0.47% | -7.96% | 3.13% | 3.08% |
| ROIC | -1,045.42% | 6.48% | 2.20% | -1.36% | 3.32% | -0.44% | 4.92% | 4.79% |
| Gross margin | 20.76% | 29.22% | 30.93% | 30.02% | 31.33% | 17.80% | 26.55% | 26.87% |
| EBITDA margin | -80.58% | 18.15% | 12.90% | 7.90% | 18.28% | 11.85% | 24.28% | 20.42% |
| Net margin | -118.94% | -10.11% | -19.32% | -21.00% | -0.49% | -10.49% | 3.85% | 3.72% |
| Net debt/EBITDA | — | 2.75 | 5.43 | 14.34 | 4.52 | 7.64 | 3.41 | 3.68 |
AALR3 financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | R$1.2bn | R$1.2bn | R$1.2bn | R$1.1bn | R$1.1bn | R$928.8m |
| Cost of sales | -R$914.3m | -R$861.3m | -R$814.8m | -R$759.3m | -R$780.5m | -R$763.5m |
| Gross profit | R$239.5m | R$355.7m | R$364.8m | R$325.7m | R$356m | R$165.3m |
| EBITDA | -R$929.7m | R$220.8m | R$152.2m | R$85.7m | R$207.8m | R$110.1m |
| EBIT | -R$1bn | R$113m | R$38.9m | -R$32m | R$88.2m | -R$9.1m |
| Net finance result | -R$233.2m | -R$208.5m | -R$238.4m | -R$201.2m | -R$85.7m | -R$63.9m |
| Profit before tax | -R$1.3bn | -R$95.5m | -R$199.5m | -R$233.2m | R$2.5m | -R$73.1m |
| Income tax | -R$84.2m | -R$15.8m | -R$19.1m | R$14m | -R$468k | -R$19.4m |
| Net income | -R$1.4bn | -R$123.1m | -R$227.9m | -R$227.8m | -R$5.6m | -R$97.4m |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
AALR3 against its sector
The same indicators for the company's other shares and the sector's largest stocks.
| Stock | P/E | P/B | Dividend yield (12m) | ROE | Market cap |
|---|---|---|---|---|---|
| AALR3Alliança | -0.38 | -1.87 | 0.00% | 494.46% | R$501.3m |
| RDOR3REDE DOR SÃO LUIZ S.A. | 17.86 | 4.15 | 10.94% | 23.26% | R$86.1bn |
| SAUD3SAUD3 | 37.09 | 2.09 | 3.05% | 5.63% | R$39.1bn |
| FLRY3FLEURY S.A. | 18.41 | 2.39 | 5.48% | 13.00% | R$13bn |
| DASA3DIAGNOSTICOS DA AMERICA S.A. | -5.54 | 0.72 | 0.00% | -13.09% | R$5bn |
| HAPV3HAPVIDA PARTICIPACOES E INVESTIMENTOS SA | -20.50 | 0.07 | 0.00% | -0.36% | R$3.6bn |
| MATD3HOSPITAL MATER DEI S/A | 11.95 | 1.14 | 2.96% | 9.50% | R$1.7bn |
Does AALR3 pay dividends?
Dividend yield per year
- 0.47%2019
- 1.57%2020
- 0.00%2021
- 0.00%2022
- 0.00%2023
- 0.00%2024
- 0.00%2025
- 0.00%2026
| Type | Last day to own | Payment | Per share |
|---|---|---|---|
| Dividend | 09/12/2020 | 18/12/2020 | R$0.09 |
| Dividend | 27/04/2020 | 18/12/2020 | R$0.09 |
| Dividend | 25/04/2019 | 07/05/2019 | R$0.06 |
| Dividend | 25/04/2019 | 07/05/2019 | R$0.03 |
About Alliança
- Sector
- Saúde
- Segment
- Serv.Méd.Hospit..Análises e Diagnósticos
- Listing segment
- Novo Mercado
- Tag along
- 100.00%
- Free float
- 40.17%
- Shares issued
- 152.36m ordinary
- Average daily trading
- R$175.6k
- Listed since
- 28/10/2016
- CNPJ
- 42.771.949/0001-35
A Alliança Saúde e Participações S.A. (AALR3), conhecida historicamente como Alliar, atua no segmento de medicina diagnóstica no Brasil, com serviços de imagem, análises clínicas e exames especializados. A companhia opera por meio de rede própria e unidades parceiras, atendendo pacientes particulares, operadoras de saúde e contratos corporativos. O modelo de negócios combina prestação ambulatorial, suporte diagnóstico hospitalar e gestão de capacidade técnica para diferentes regiões do país. No ambiente de mercado, a empresa concorre com grupos de diagnóstico de maior escala e com operadores regionais, em um setor com pressão de custos, regulação sanitária e necessidade contínua de investimento em equipamentos e sistemas. Sua operação depende de eficiência de agenda, produtividade de exames e negociação com pagadores, além de padronização clínica e controle de qualidade. O foco operacional está em manter capilaridade de atendimento e sustentabilidade financeira em um segmento sensível a volume e preço.
Investor website| Shareholder | Ordinary | Preferred | Total |
|---|---|---|---|
| TESSAI FUNDO DE INVESTIMENTO EM PARTICIPACOES MULTControlling | 59.84% | 0.00% | 59.84% |
| YVRAC FUNDO DE INVESTIMENTO EM PARTICIPAÇÕES MULTIESTRATEGIA | 10.86% | 0.00% | 10.86% |
| FUNDO DE INVESTIMENTO FINANCEIRO MULTIMERCADO SAÚDE CREDITO | 9.14% | 0.00% | 9.14% |
| FUNDAÇÃO DE SEGURIDADE DE SOCIAL BRASLIGHT | 6.57% | 0.00% | 6.57% |
| Fonte de Saúde FI EM Participações Multiestratégia | 5.71% | 0.00% | 5.71% |
| Outros | 7.86% | 0.00% | 7.86% |
| Ações Tesouraria | 0.03% | 0.00% | 0.03% |
Questions about AALR3
How much is AALR3 today?
AALR3 is at R$3.40 (3.03% on the day), last traded on 02/10/2026.
How much did AALR3 pay in dividends in 2025?
AALR3 paid R$0.00 per share in 2025, a dividend yield of 0.00%.
What are the P/E and P/B of AALR3?
AALR3 trades at a P/E of -0.38 and a P/B of -1.87.
How much did AALR3 return in 12 months?
AALR3 returned -47.01% in 12 months, with annualised volatility of 52.59% and a largest drawdown of -52.18%.
What sector is AALR3 in?
Alliança is in the Saúde sector, Serv.Méd.Hospit..Análises e Diagnósticos segment.